Nike
NKE
$36.05
-0.14%
Nike, Inc. is the world's largest athletic footwear and apparel company, designing and marketing footwear, apparel, equipment, and accessories under the Nike, Jordan, Converse, and NikeSkims brands, with footwear accounting for roughly two-thirds of sales. The company operates a vertically integrated model combining wholesale distribution, company-owned retail, and a global e-commerce platform spanning more than 40 countries, while outsourcing nearly all production to contract manufacturers across 30-plus countries. Nike's competitive identity rests on unmatched brand equity, deep athlete endorsement portfolios, and category leadership in basketball, running, and soccer, though it now faces intensifying competition from On, Hoka, and a resurgent Adidas. The current investor narrative is dominated by a severe multi-year downturn: the stock has fallen to a 12-year low amid tariff headwinds, weak Greater China demand, and sluggish revenue growth, with the debate centering on whether gross margin recovery and a new product cycle can engineer a turnaround or whether the brand has suffered structural share loss.…
NKE
Nike
$36.05
Related headlines
Investment Opinion: Should I buy NKE Today?
The synthesized recommendation is Hold, with a clear thesis that Nike's deep value and brand strength are offset by unconfirmed revenue stabilization and earnings volatility. The analyst consensus rating of 'hold' (recommendation mean 2.73) and average target price of $48.21 imply 35.8% upside, but the lack of recent upgrades and a 70/30 split favoring caution suggest the market is in wait-and-see mode. The stock is not a screaming buy until there is tangible evidence of a turnaround, but the downside appears limited given the 3.53% dividend yield and low PS ratio of 1.47x.
Supporting evidence for a Hold includes: (1) the forward PE of 15.52x is roughly in line with or slightly below sector norms, implying the market is pricing Nike as an average cyclical despite its premium brand; (2) revenue growth is negative at -1.13% year-over-year, but the Q4 gross margin of 49.15% shows potential for margin recovery; (3) free cash flow of $2.18 billion trailing and a current ratio of 1.96 demonstrate financial stability; and (4) the implied upside to the analyst average target is 35.8%, but the wide range ($23-$94) signals low conviction. Compared to the broader Consumer Cyclical sector, Nike's PS of 1.47x is low, but its PB of 4.58x and PCF of 23.74x suggest a premium is still embedded for brand and cash generation.
The biggest risks that could invalidate the thesis are: (1) a breakdown below the 52-week low of $35.50, which would confirm the downtrend and potentially target the analyst low of $23; (2) a dividend cut if earnings continue to decline, given the 77.45% payout ratio; and (3) intensifying competition and tariff headwinds pressuring margins. The rating would upgrade to Buy if revenue stabilizes and gross margin holds above 45% for two consecutive quarters, or if the stock breaks above $40 on strong volume. It would downgrade to Sell if revenue declines accelerate below -5% year-over-year or if the dividend is cut. Relative to its history and peers, Nike appears undervalued on a PS basis but fairly valued on a forward PE basis, suggesting the stock is pricing in a successful turnaround without giving credit for a margin of safety.
Sign up to view all
NKE 12-Month Price Forecast
Nike presents a classic turnaround bet with significant uncertainty. The stock is deeply oversold at a 12-year low, and the forward PE of 15.52x suggests the market is pricing in an earnings recovery that has not yet materialized. The bull case hinges on sustainable gross margin expansion and revenue stabilization, while the bear case fears structural brand impairment and further share loss. Analyst sentiment is neutral with a wide target range, reflecting low conviction. I would upgrade to bullish if revenue growth turns positive and gross margin holds above 46% for two consecutive quarters, and downgrade to bearish if revenue declines accelerate or the dividend is cut. Given the balanced risk/reward, a neutral stance with a medium confidence is appropriate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nike's 12-month outlook, with a consensus price target around $47.74 and implied upside of +32.4% versus the current price.
Average Target
$47.74
0 analysts
Implied Upside
+32.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$23 - $94
Analyst target range
Nike is covered by 36 analysts, and the consensus recommendation is 'hold' with a recommendation mean of 2.73 (where 1 is strong buy and 5 is strong sell), indicating a neutral-to-cautious stance. The average target price is $48.21, which implies 35.8% upside from the current price of $35.51 — a substantial gap that reflects either significant undervaluation or analyst reluctance to mark down targets as quickly as the stock has fallen. The consensus leans neutral rather than bullish: the 'hold' rating combined with a target 36% above the current price suggests analysts see value but lack conviction in a near-term catalyst. The estimated EPS average of $3.00 for the forward year, against a forward PE of 15.52x, implies the market is pricing in roughly $2.29 in earnings — well below analyst estimates — highlighting the disconnect between analyst expectations and market pricing.
The target price range is extraordinarily wide, from a low of $23.00 to a high of $94.00 — a 309% spread that signals very low conviction and high uncertainty about Nike's future. The high target of $94.00 implies a scenario where Nike's brand recovers, gross margins expand durably, Greater China stabilizes, and the market re-rates the stock back toward historical multiples; this would require both earnings growth and multiple expansion. The low target of $23.00 prices in continued revenue decline, margin compression, tariff escalation, and further share loss to competitors — essentially a value trap scenario. Institutional ratings from July 2026 show a clear split: B of A, Wells Fargo, BNP Paribas, Stifel, Telsey, UBS, and Citigroup all maintain Neutral/Hold/Underperform ratings, while Baird, Jefferies, and Bernstein maintain Outperform/Buy — a roughly 70/30 split favoring caution. Notably, there were no upgrades in the visible ratings data, and the presence of an Underperform rating from BNP Paribas indicates some analysts see further downside. The wide target spread and lack of recent upgrades suggest the market is in a wait-and-see mode, and the stock is likely to remain volatile until Nike demonstrates tangible progress on its turnaround.
Bulls vs Bears: NKE Investment Factors
The bear case currently has stronger evidence, driven by accelerating revenue contraction, a stock at a 12-year low with no technical support, and extreme earnings volatility. The bull case rests on deep value (PS of 1.47x), a potential gross margin recovery (Q4 at 49.15%), and a 36% upside to analyst targets, but these are forward-looking hopes rather than confirmed trends. The single most important tension is whether the Q4 gross margin improvement is sustainable or a one-time benefit; if it proves durable and revenue stabilizes, the stock could re-rate sharply, but if margins revert and revenue continues to decline, the downtrend will persist. With a relative strength of -65.76% over 12 months and no upgrades in recent analyst ratings, the market is clearly pricing in a worst-case scenario, and the burden of proof is on Nike to demonstrate a turnaround.
Bullish
- Deep value on price-to-sales: Nike trades at a PS ratio of 1.47x, the lowest level in the entire historical dataset and an 88% collapse from 12.61x in Q4 2023. For a brand with $46.4 billion in estimated forward revenue and a 3.53% dividend yield, this suggests the market is pricing in a worst-case scenario that may be overdone.
- Gross margin recovery underway: Q4 2026 gross margin expanded to 49.15% from 40.16% in Q3 and 40.60% in Q2, a nearly 900 basis point sequential improvement. If this level is sustained, it would mark a return to Nike's historical 44-46% range and drive significant earnings leverage.
- Analyst target implies 36% upside: The consensus average target price of $48.21 implies 35.8% upside from the current $35.51, with 36 analysts covering the stock. Even the recommendation mean of 2.73 (hold) suggests analysts see value but are waiting for a catalyst.
- Strong balance sheet and cash flow: Nike maintains a current ratio of 1.96, debt-to-equity of 0.74, and generated $2.18 billion in trailing free cash flow. With $7.56 billion in cash, the company has ample liquidity to fund its turnaround and sustain its dividend.
Bearish
- Revenue contraction accelerating: Q4 2026 revenue fell 1.13% year-over-year to $10.97 billion, the lowest quarterly revenue in the trailing eight-quarter dataset. The sequential decline from $12.43 billion to $11.28 billion to $10.97 billion shows the business is shrinking, not just decelerating.
- Stock at 12-year low with no support: NKE closed at $35.51, just $0.01 above its 52-week low of $35.50, and is down 50.75% over the past year and 43.88% year-to-date. With a max drawdown of -55.15%, the stock is in price-discovery territory with no established technical support.
- Earnings volatility and margin instability: Quarterly gross margin swung from 40.16% to 49.15% in just two quarters, and net margin collapsed to 4.61% in Q3 2026 before recovering to 9.74% in Q4. This volatility signals operational instability and makes forecasting unreliable.
- High payout ratio limits flexibility: The dividend payout ratio of 77.45% against a 3.53% yield means Nike is paying out the vast majority of earnings, leaving limited retained capital for reinvestment. If earnings continue to fall, the dividend could be at risk.
NKE Technical Analysis
Nike is in a pronounced, sustained downtrend, with the stock down 50.75% over the past year and 43.88% year-to-date, closing at $35.51 against a 52-week range of $35.50 to $76.97. That places the shares at effectively 0% of their 52-week range — literally at the 52-week low — a positioning that signals persistent selling pressure and momentum-driven weakness rather than a value floor. The maximum drawdown of -55.15% underscores the severity of the decline, and with the current price sitting just one cent above the 52-week low, the stock is in price-discovery territory with no established technical support beneath it. For investors, this is the classic 'falling knife' profile: deeply oversold but lacking any confirmation of a bottom, meaning any entry carries substantial timing risk until a higher low is established.
Short-term momentum is decisively negative and accelerating to the downside: the stock is down 13.50% over the past month and 21.44% over three months, with the 1-month decline steeper than the 3-month decline, indicating the selloff is intensifying rather than stabilizing. This contrasts sharply with the broader market, as SPY gained 15.01% over the past year while Nike lost 50.75%, producing a staggering relative strength of -65.76% over 12 months and -12.54% over just the past month. The divergence between Nike's accelerating decline and SPY's modest 1-month loss of 0.96% confirms that this is company-specific deterioration, not a market-wide risk-off event. With no RSI data provided, the sheer velocity of the decline — including a 2.34% single-day drop on the most recent session — suggests deeply oversold conditions that could produce a technical bounce, but such bounces in a structural downtrend are typically selling opportunities rather than trend reversals.
Key technical levels are stark: the 52-week low of $35.50 is the immediate support, and the stock closed just $0.01 above it, meaning any further weakness would mark new multi-year lows with the next psychological support likely around $30-$32. Resistance is layered far above, beginning with the $40 round number that the stock repeatedly failed to hold in July and August 2026, then the 52-week high of $76.97 — a level 117% above the current price. A breakout above $40 on strong volume would be the first meaningful signal of a trend change, while a breakdown below $35.50 would confirm the downtrend's continuation. With a beta of 1.11, Nike is only modestly more volatile than the market, but the stock's 55% drawdown vastly exceeds what that beta would predict, indicating that idiosyncratic company risk — not market beta — is the dominant driver of losses, which matters greatly for position sizing.
Beta
1.11
1.11x market volatility
Max Drawdown
-55.1%
Largest decline past year
52-Week Range
$35-$77
Price range past year
Annual Return
-49.2%
Cumulative gain past year
| Period | NKE Return | S&P 500 |
|---|---|---|
| 1m | -11.5% | +0.6% |
| 3m | -11.9% | +4.6% |
| 6m | -29.8% | +21.1% |
| 1y | -49.2% | +15.8% |
| ytd | -43.0% | +12.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NKE Fundamental Analysis
Nike's revenue trajectory has stalled and is now contracting: the most recent quarter (ending May 31, 2026) delivered revenue of $10.97 billion, down 1.13% year-over-year, following $11.28 billion in the prior quarter and $12.43 billion two quarters before that. The sequential decline from $12.43 billion to $11.28 billion to $10.97 billion reveals a business that is shrinking, not merely decelerating, and the Q4 figure was the lowest quarterly revenue in the trailing eight-quarter dataset. By segment, footwear remains the dominant contributor at $15.04 billion and apparel at $7.57 billion, but the absence of segment-level growth rates makes it difficult to isolate whether footwear or apparel is the primary drag — though the overall revenue decline suggests broad-based weakness. For the investment case, this is the central problem: a turnaround requires revenue stabilization first, and Nike has not yet demonstrated it.
Profitability remains positive but is under visible pressure. Q4 net income was $1.07 billion on a net margin of 9.74%, with a gross margin of 49.15% — a notable improvement from the 40.16% gross margin in Q3 and 40.60% in Q2, suggesting some margin recovery is underway. However, the trailing gross margin of 42.91% and operating margin of 8.19% remain well below Nike's historical norms of 44-46% gross margin, and the Q3 net margin of just 4.61% illustrates how quickly profitability can erode when gross margins compress. The Q4 gross margin of 49.15% may reflect one-time benefits or favorable mix rather than a durable trend, and investors should be cautious about extrapolating a single quarter's improvement. Compared to typical apparel/footwear industry gross margins of 40-50%, Nike remains in the upper tier, but the volatility in quarterly margins — swinging from 40.16% to 49.15% in two quarters — signals operational instability.
Nike's balance sheet remains a source of strength even as the income statement deteriorates. The current ratio of 1.96 and debt-to-equity of 0.74 indicate adequate liquidity and moderate leverage, while the trailing free cash flow of $2.18 billion and Q4 free cash flow of $1.50 billion demonstrate the business still generates cash. However, the FCF trend is concerning: free cash flow fell from $1.71 billion in Q3 2025 to just $15 million in Q1 2026 before recovering to $1.50 billion in Q4 2026, a highly volatile pattern driven by working capital swings. Return on equity of 20.91% and return on assets of 6.97% remain respectable, but the dividend payout ratio of 77.45% against a dividend yield of 3.53% means Nike is paying out the vast majority of earnings to shareholders, leaving limited retained capital for reinvestment in the turnaround. With $7.56 billion in cash at the end of Q4 2026, Nike has a cushion, but the combination of high payout ratio, volatile FCF, and declining revenue limits financial flexibility.
Quarterly Revenue
$11.0B
2026-05
Revenue YoY Growth
-1.1%
YoY Comparison
Gross Margin
49.1%
Latest Quarter
Free Cash Flow
$2.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NKE Overvalued?
Because Nike remains profitable — Q4 net income of $1.07 billion and trailing EPS of $0.0456 — the PE ratio is the appropriate primary valuation metric. The trailing PE stands at 21.87x, while the forward PE is 15.52x, a 29% discount that implies the market expects meaningful earnings growth over the next twelve months. However, this expectation must be weighed against the reality that revenue is declining 1.13% year-over-year and the trailing PE of 21.87x is based on depressed earnings — if earnings fall further, the effective multiple rises. The forward PE of 15.52x is only attractive if the earnings recovery materializes, making it a bet on the turnaround rather than a straightforward value signal.
Relative to the broader Consumer Cyclical sector, Nike's valuation presents a mixed picture. The price-to-sales ratio of 1.47x and EV/Sales of 1.21x are low in absolute terms, but the price-to-book of 4.58x and price-to-cash-flow of 23.74x suggest the market is still assigning a premium to Nike's brand and cash generation. The PEG ratio of -6.78 is negative and therefore not meaningful, reflecting the earnings decline rather than a valuation signal. Compared to a typical consumer cyclical peer trading at 15-20x earnings, Nike's trailing PE of 21.87x represents a modest premium, but the forward PE of 15.52x is roughly in line with or slightly below sector norms — implying the market is pricing Nike as an average cyclical despite its premium brand. The dividend yield of 3.53% is well above Nike's historical average and provides some valuation support, but the 77.45% payout ratio raises questions about sustainability if earnings continue to fall.
Historically, Nike's valuation has compressed dramatically. The PE ratio has fallen from 108.20x in Q4 2025 to 21.87x currently, while the PS ratio has collapsed from 12.61x in Q4 2023 to 1.47x today — a decline of 88%. The price-to-book ratio has fallen from 11.55x in Q4 2023 to 4.58x, and the dividend yield has risen from 0.32% to 3.53%, reflecting both the price collapse and the market's demand for higher yield as compensation for risk. On a PS basis, Nike is trading at the lowest level in the entire historical dataset, which could signal deep value — or could reflect a permanent impairment of the brand's growth premium. The market is clearly pricing in a worst-case scenario, and the question for investors is whether that pessimism is overdone or justified by the fundamental deterioration.
PE
21.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 16x~50x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.6x
Enterprise Value Multiple
Investment Risk Disclosure
Nike's financial and operational risks are significant and quantifiable. Revenue is contracting, with Q4 2026 revenue of $10.97 billion down 1.13% year-over-year and the lowest in eight quarters, while net margin has been volatile, swinging from 4.61% in Q3 to 9.74% in Q4. The dividend payout ratio of 77.45% leaves little room for error, and free cash flow has been erratic, falling from $1.71 billion in Q3 2025 to just $15 million in Q1 2026 before recovering to $1.50 billion in Q4 2026. With $7.56 billion in cash and a current ratio of 1.96, liquidity is adequate, but the combination of declining revenue, high payout, and volatile cash flow limits financial flexibility to invest in a turnaround.
Market and competitive risks are equally pressing. Nike's trailing PE of 21.87x is a premium to the typical consumer cyclical peer at 15-20x, but this is based on depressed earnings; if earnings fall further, the effective multiple rises. The forward PE of 15.52x is only attractive if the earnings recovery materializes, making it a bet on the turnaround. The stock's beta of 1.11 suggests modest market correlation, but its 55% drawdown vastly exceeds what beta would predict, indicating idiosyncratic company risk is dominant. Competitive threats from On, Hoka, and Adidas are intensifying, and the shift to Section 301 tariffs covering 60 countries at 10-12.5% rates adds a durable cost headwind that could pressure gross margins.
The worst-case scenario involves a continued revenue decline, margin compression, and further share loss, leading to a breakdown below the 52-week low of $35.50. The analyst low target of $23.00 represents a 35% downside from the current price, and the stock has already fallen 55.15% from its peak. If Nike fails to stabilize revenue and the Q4 gross margin improvement proves temporary, the stock could retest the $30-$32 psychological support, implying a further 10-15% decline. In a more severe scenario where the dividend is cut and earnings disappoint, the shares could approach the $23 low target, representing a 35% loss from current levels. Investors should be prepared for significant volatility given the lack of technical support and the wide analyst target range of $23 to $94.
FAQ
The key risks include: (1) Financial risk: revenue is contracting at -1.13% year-over-year, and the dividend payout ratio of 77.45% leaves little room for error if earnings decline further. (2) Competitive risk: Nike is losing share to On, Hoka, and a resurgent Adidas, which could permanently impair its brand premium. (3) Macro risk: the shift to Section 301 tariffs covering 60 countries at 10-12.5% rates adds a durable cost headwind that could pressure gross margins. (4) Company-specific risk: the stock is at a 12-year low with no technical support, and a breakdown below $35.50 could trigger further selling. Ranked by severity, the financial and competitive risks are most immediate, followed by macro and company-specific risks.
The 12-month forecast includes three scenarios: bull case (25% probability) with a target range of $60-$94, base case (55% probability) with a target range of $40-$55, and bear case (20% probability) with a target range of $23-$35. The base case is most likely, assuming revenue declines moderate and gross margin stabilizes in the mid-40s, leading the stock to trade around the analyst average target of $48.21. The bull case requires a successful turnaround with revenue growth and margin expansion, while the bear case assumes continued deterioration and a dividend cut. The key assumption behind the base case is that Nike meets the analyst EPS estimate of $3.00 and maintains its dividend.
NKE appears undervalued on a price-to-sales basis, trading at 1.47x, the lowest in its historical dataset and an 88% decline from 12.61x in Q4 2023. However, on a trailing PE basis, it trades at 21.87x, a premium to the typical consumer cyclical peer at 15-20x, though this is based on depressed earnings. The forward PE of 15.52x is roughly in line with sector norms, suggesting the market is pricing Nike as an average cyclical despite its premium brand. The dividend yield of 3.53% is well above its historical average, providing some valuation support. Overall, the market is pricing in a worst-case scenario, and the stock could be undervalued if the turnaround materializes, but it is not a straightforward value play given the earnings uncertainty.
NKE is a high-risk, high-reward turnaround play that may be suitable for patient investors with a long time horizon. The stock trades at $35.51, just above its 52-week low of $35.50, and offers a 3.53% dividend yield, but it has fallen 50.75% over the past year due to revenue declines and margin pressure. The analyst average target of $48.21 implies 35.8% upside, but the wide range of $23 to $94 reflects low conviction. The biggest downside risk is a breakdown below $35.50, which could target the analyst low of $23, representing a 35% loss. For those willing to accept volatility, a small position with a multi-year view could be justified, but waiting for confirmation of revenue stabilization and gross margin sustainability is prudent.
NKE is more suitable for long-term investment given its current turnaround phase, high volatility (beta of 1.11), and dividend yield of 3.53%. The stock has fallen 50.75% over the past year and is at a 12-year low, making it a falling knife for short-term traders. The company's earnings visibility is low, with quarterly gross margins swinging from 40.16% to 49.15%, and revenue declining. A long-term investor with a horizon of at least 3-5 years could benefit from a potential recovery, but short-term trading is highly risky due to the lack of technical support and the wide analyst target range. A minimum holding period of 2-3 years is suggested to allow the turnaround to materialize.

